SEARCH

Current Edition

Food and Drug Administration

Lilly pours more money into genetic treatments for neurological diseases

With its potential to treat an enormous range of diseases, genetic medicine has become a focal point for many large drug companies. Novartis, for instance, …

Continue Reading →